Our previous study had confirmed that ATG9B-4 could promote the malignant characteristics of liver cancer cells by up-regulating the expression of CDK5.[10] And the above study also concluded that ATG9B-4 accelerated the proliferation and migration by down-regulating the expression of ARNTL. The gene discussed is BMAL1; the disease is liver cancer.